AlloVir Aktie
WKN DE: A2QAMR / ISIN: US0198181036
22.06.2023 22:44:24
|
AlloVir Prices Public Offering
(RTTNews) - Clinical-stage cell therapy company AlloVir, Inc. (ALVR), on Thursday announced pricing of its public offering.
AlloVir shares closed at $3.17 down 35% or $1.76 per share at the Nasdaq, after the company said it priced a public offering of 20 million shares at $3.75 a share to the public.
The gross proceeds from the offering are expected to be $75.0 million. The offering is expected to close on or about June 26, 2023.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu AlloVir Inc Registered Shsmehr Nachrichten
Keine Nachrichten verfügbar. |